The manufacturers of the most popular slimming products are clashing: they have already gone to court.

Novo Nordisk, a Danish pharmaceutical company, has announced that it is seeking a temporary court order in the United States to immediately halt the advertising campaigns of its largest competitor, Eli Lilly, which promote the company’s weight loss and diabetes medications.